137
Participants
Start Date
June 22, 2017
Primary Completion Date
September 25, 2019
Study Completion Date
November 24, 2019
AMX0035
AMX0035
Placebo
Matching Placebo Comparator
Mount Sinai Beth Israel, New York
The Penn Comprehensive ALS Center, Philadelphia
Temple University Hospital, Philadelphia
Johns Hopkins Hospital, Baltimore
Wake Forest Baptist Medical Center, Winston-Salem
Emory University Hospital, Atlanta
University of Florida Medical Center, Gainesville
Carol and Frank Morsini Center for Advanced Health Care - University of South Florida, Tampa
University of Kentucky Medical Center, Lexington
The Ohio State University Wexner Medical Center, Columbus
University of Michigan Medical Center, Ann Arbor
University of Iowa Hospitals and Clinics, Iowa City
Hennepin County Medical Center, Minneapolis
Washington University Medical Center, St Louis
Neurology Associates P.C., Lincoln
Ochsner Neuroscience Institute, New Orleans
Texas Neurology, P.A., Dallas
University of Texas Health Science Center at San Antonio, San Antonio
Barrow Neurological Institute, Phoenix
UC Irvine Medical Center, Orange
Forbes Norris MDA/ALS Research Center - California Pacific Medical Center, San Francisco
Oregon Health & Science University, Portland
ALS Center at the Swedish Neuroscience Institute, Seattle
Massachusetts General Hospital, Boston
University of Massachusetts Memorial Medical Center, Worcester
Lead Sponsor
ALS Finding a Cure
OTHER
ALS Association
OTHER
Northeast ALS Consortium
OTHER
Neurological Clinical Research Institute at Massachusetts General Hospital
OTHER
Leandro P. Rizzuto Foundation
OTHER
Amylyx Pharmaceuticals Inc.
INDUSTRY